2.7. Neuraminidase inhibition (NAI) assay

IK Ingrid Karlsson
MB Marie Borggren
MR Maiken Worsøe Rosenstierne
RT Ramona Trebbien
JW James A. Williams
EV Enric Vidal
JV Júlia Vergara-Alert
DF David Solanes Foz
AD Ayub Darji
MS Marta Sisteré-Oró
JS Joaquim Segalés
JN Jens Nielsen
AF Anders Fomsgaard
ask Ask a question
Favorite

The neuraminidase inhibition activity was determined using the NA-Fluor Influenza Neuraminidase Assay kit (Life technologies) according to the manufactures protocol, where serum and virus was allowed to incubate 30 min at 37 °C before adding the NA-Fluor™ Substrate. The two virus strains, A/California/07/09 (H1N1)pdm09 and A/swine/DK/10496/2008 (H1N1), were used at 1:10 dilution, determined to give a relative fluorescence unit (RFU) within the linear range. Serum from day −36, day 0 and day 13 pc were tested at 4-fold dilutions starting at 1:10 up to 1:1040. Non-linear regression, with log-transformed serum dilutions as the independent variable, was performed to calculate the serum dilution that would inhibit 50% NA activity (IC50) (Graph-Pad Prism software).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A